Form 4: MapLight Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Anatol Kreitzer, Chief Discovery Officer of MapLight Therapeutics, Inc., sold 36,284 shares of common stock on July 15, 2026.
Summary
- Open-market sale: disposed of 5,545 Voting Common Stock at $36.13 ($200,341) on July 15, 2026; holds 205,645 after (Direct).
- Open-market sale: disposed of 4,510 Voting Common Stock at $36.94 ($166,599) on July 15, 2026; holds 201,135 after (Direct).
- Open-market sale: disposed of 7,464 Voting Common Stock at $36.66 ($273,630) on July 16, 2026; holds 193,671 after (Direct).
- Open-market sale: disposed of 1,592 Voting Common Stock at $37.44 ($59,604) on July 16, 2026; holds 192,079 after (Direct).
- Open-market sale: disposed of 2,833 Voting Common Stock at $37.05 ($104,963) on July 17, 2026; holds 189,246 after (Direct).
- Open-market sale: disposed of 14,140 Voting Common Stock at $37.70 ($533,078) on July 17, 2026; holds 175,106 after (Direct).
- Open-market sale: disposed of 200 Voting Common Stock at $38.39 ($7,678) on July 17, 2026; holds 174,906 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,345,894 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Anatol Kreitzer — Officer (Chief Discovery Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Open-market sale | Voting Common Stock | 5,545 | $36 | $200.3K | 205,645 |
| 2026-07-15 | Open-market sale | Voting Common Stock | 4,510 | $37 | $166.6K | 201,135 |
| 2026-07-16 | Open-market sale | Voting Common Stock | 7,464 | $37 | $273.6K | 193,671 |
| 2026-07-16 | Open-market sale | Voting Common Stock | 1,592 | $37 | $59.6K | 192,079 |
| 2026-07-17 | Open-market sale | Voting Common Stock | 2,833 | $37 | $105.0K | 189,246 |
| 2026-07-17 | Open-market sale | Voting Common Stock | 14,140 | $38 | $533.1K | 175,106 |
| 2026-07-17 | Open-market sale | Voting Common Stock | 200 | $38 | $7.7K | 174,906 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Open-market sale (5,545 shares) |
| 2026-07-15 | Open-market sale (4,510 shares) |
| 2026-07-16 | Open-market sale (7,464 shares) |
| 2026-07-16 | Open-market sale (1,592 shares) |
| 2026-07-17 | Open-market sale (2,833 shares) |
| 2026-07-17 | Open-market sale (14,140 shares) |
| 2026-07-17 | Open-market sale (200 shares) |
Keywords
insider transaction, Form 4, MPLT, MapLight Therapeutics, Inc., bearish, Anatol Kreitzer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.